Bernadette is a physician by training and has worked over 35 years in the pharmaceutical industry where she gained extensive expertise in clinical trials, regulatory affairs, pharmacovigilance, documentation, crisis management and medical affairs - managing up to 450 people at times. The last 20 years she has been devoted to vaccinology both at GSK bio and Sanofi Pasteur. She was a board member and Chair for the technical working group of Vaccines Europe (part of EFPIA) for 8 years, and managed up to 450 people spread mainly over France, the USA and Canada. Since January 2015 she started her own Consultancy Science Applied to Human Biology that focuses on the pharmaceutical industry (Regulatory Affairs, Pharmacovigilance, Crisis Management, training).
The Synergist runs programmes aimed at solving challenges which others ignore or have been unable to resolve. Our approach is a bit different. We’re not issue experts. We focus primarily on bringing the most important stakeholders together and building shared value, rather than trying to do it all ourselves. Given the complexity of the world we live in and the challenges we face, we’re convinced there is no better way.
The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework. PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.